Falfurrias Management Partners completed the investment in Jumo Health.

Falfurrias Management Partners, a private equity firm focused on growth-oriented, middle-market businesses, completed the investment in Jumo Health, a clinical trial solutions company driving better outcomes for clinical trials globally. Financial terms were not dislcosed. “Treatment advancements for increasingly targeted patient populations depend on more diverse and innovative clinical trial solutions. As treatments become more personalized and trial complexity increases, the need for effective patient communications is more critical than ever," Adam Cossman, Falfurrias Executive Advisor.